Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Hudson, KE, Rizzieri, D, Thomas, SM, LeBlanc, TW, Powell, Z, Diehl, L, Moore, JO, DeCastro, C, and Beaven, AW. "Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study." British Journal of Haematology 184, no. 4 (February 2019): 647-650. (Letter)
Schwartz, AJ, Riedel, RF, LeBlanc, TW, Desai, D, Jenkins, C, Mahoney, E, Humphreys, J, and Hendrix, CC. "The experiences of older caregivers of cancer patients following hospital discharge." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer 27, no. 2 (February 2019): 609-616.
Lee, ES, Suh, S-Y, LeBlanc, TW, Himchack, SH, Lee, SS, Kim, Y, and Ahn, H-Y. "Korean Physicians' Perspectives on Prognostication in Palliative Care: A Qualitative Study." The American Journal of Hospice & Palliative Care (January 27, 2019): 1049909118824542-null.
Sarantopoulos, S, Cardones, AR, and Sullivan, KM. "How we treat refractory chronic graft-versus-host disease." Blood (January 23, 2019).
Volkmann, ER, Tashkin, DP, Sim, M, Li, N, Goldmuntz, E, Keyes-Elstein, L, Pinckney, A, Furst, DE, Clements, PJ, Khanna, D, Steen, V, Schraufnagel, DE, Arami, S, Hsu, V, Roth, MD, Elashoff, RM, Sullivan, KM, and SLS I and SLS II study groups, . "Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts." Annals of the Rheumatic Diseases 78, no. 1 (January 2019): 122-130.
Zheng, J, Sha, Y, Roof, L, Foreman, O, Lazarchick, J, Venkta, JK, Kozlowski, C, Gasparetto, C, Chao, N, Ebens, A, Hu, J, and Kang, Y. "Pan-PIM kinase inhibitors enhance Lenalidomide's anti-myeloma activity via cereblon-IKZF1/3 cascade." Cancer Letters 440-441 (January 2019): 1-10.
Wierda, WG, Byrd, JC, Abramson, JS, Bilgrami, SF, Bociek, G, Brander, D, Brown, J, Chanan-Khan, AA, Chavez, JC, Coutre, SE, Davis, RS, Fletcher, CD, Hill, B, Kahl, BS, Kamdar, M, Kaplan, LD, Khan, N, Kipps, TJ, Ma, S, Malek, S, Mato, A, Mosse, C, Neppalli, VT, Shadman, M, Siddiqi, T, Stephens, D, Wagner, N, Dwyer, MA, and Sundar, H. "NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019." Journal of the National Comprehensive Cancer Network : Jnccn 17, no. 1 (January 2019): 12-20.
Tenner, L, Hlubocky, FJ, Blanke, CD, LeBlanc, TW, Marron, JM, McGinnis, MM, Spence, RA, and Taylor, LP. "Let's Talk About Those Herbs You Are Taking: Ethical Considerations for Communication With Patients With Cancer About Complementary and Alternative Medicine." Journal of Oncology Practice 15, no. 1 (January 2019): 44-49.
Gopalakrishnan, S, D'Souza, A, Scott, E, Fraser, R, Davila, O, Shah, N, Gale, RP, Kamble, R, Diaz, MA, Lazarus, HM, Savani, BN, Hildebrandt, GC, Solh, M, Freytes, CO, Lee, C, Kyle, RA, Usmani, SZ, Ganguly, S, Assal, A, Berdeja, J, Kanate, AS, Dhakal, B, Meehan, K, Kindwall-Keller, T, Saad, A, Locke, F, Seo, S, Nishihori, T, Gergis, U, Gasparetto, C, Mark, T, Nieto, Y, Kumar, S, and Hari, P. "Revised International Staging System Is Predictive and Prognostic for Early Relapse (
Horwitz, ME, Wease, S, Blackwell, B, Valcarcel, D, Frassoni, F, Boelens, JJ, Nierkens, S, Jagasia, M, Wagner, JE, Kuball, J, Koh, LP, Majhail, NS, Stiff, PJ, Hanna, R, Hwang, WYK, Kurtzberg, J, Cilloni, D, Freedman, LS, Montesinos, P, and Sanz, G. "Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology (December 4, 2018): JCO1800053-null.